Literature DB >> 15524403

Effects of N-acetylcysteine on oxidant-antioxidant balance in oleic acid-induced lung injury.

Oguz Koksel1, Ali Ozdulger, Menderes Ercil, Lulufer Tamer, Bahadir Ercan, Ugur Atik, Leyla Cinel, Ismail Cinel, Arzu Kanik.   

Abstract

The antioxidant and anti-inflammatory properties of N-acetylcysteine has been documented in many experimental lung injury models. Because intravenous injection of oleic acid induces histopathologic changes similar to those seen in human acute lung injury or acute respiratory distress syndrome, the authors evaluated the effects of N-acetylcysteine (NAC) on oxidative stress and lung damage in an oleic acid (OA)-induced lung injury model. Thirty-five rats were divided into 5 groups as sham, NAC, OA, pre-OA-NAC, and post-OA-NAC. Lung damage was induced by intravenous administration of oleic acid. Pre-OA-NACgroup received intravenous (IV) N-acetylcysteine 15 minutes before oleic acid infusion and post-OA-NAC group received IV N-acetylcysteine 2 hours after oleic acid infusion. In both of the N-acetylcysteine treatment groups, blood and tissue samples were collected 4 hours after oleic acid infusion, independent from the time of N-acetylcysteine infusion. In other groups, blood and tissue samples were collected 4 hours after ethanol, NAC, or OA infusions. Serum myeloperoxidase activity, total antioxidant capacity, malondialdehyde levels, and lung tissue Na+ - K+ ATPase activity were measured and light microscopic analyses of lung specimens were performed. The administration of N-acetylcysteine significantly restored Na+ - K+ ATPase activity and total antioxidant capacity levels and ameliorated lung architecture. N-acetylcysteine has been shown to have some attenuating effects in experimental animal studies. However, further investigations are necessary to suggest N-acetylcysteine as a treatment agent in critically ill patients with lung injury.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15524403     DOI: 10.1080/01902140490476319

Source DB:  PubMed          Journal:  Exp Lung Res        ISSN: 0190-2148            Impact factor:   2.459


  5 in total

1.  Multi-omics analyses of airway host-microbe interactions in chronic obstructive pulmonary disease identify potential therapeutic interventions.

Authors:  Zhengzheng Yan; Boxuan Chen; Yuqiong Yang; Xinzhu Yi; Mingyuan Wei; Gertrude Ecklu-Mensah; Mary M Buschmann; Haiyue Liu; Jingyuan Gao; Weijie Liang; Xiaomin Liu; Junhao Yang; Wei Ma; Zhenyu Liang; Fengyan Wang; Dandan Chen; Lingwei Wang; Weijuan Shi; Martin R Stampfli; Pan Li; Shenhai Gong; Xia Chen; Wensheng Shu; Emad M El-Omar; Jack A Gilbert; Martin J Blaser; Hongwei Zhou; Rongchang Chen; Zhang Wang
Journal:  Nat Microbiol       Date:  2022-08-22       Impact factor: 30.964

2.  Amifostine reduces lung vascular permeability via suppression of inflammatory signalling.

Authors:  P Fu; A A Birukova; J Xing; S Sammani; J S Murley; J G N Garcia; D J Grdina; K G Birukov
Journal:  Eur Respir J       Date:  2008-11-14       Impact factor: 16.671

3.  Antioxidant vitamins C, E and coenzyme Q10 vs dexamethasone: comparisons of their effects in pulmonary contusion model.

Authors:  Mertol Gokce; Ozkan Saydam; Volkan Hanci; Murat Can; Burak Bahadir
Journal:  J Cardiothorac Surg       Date:  2012-09-26       Impact factor: 1.637

4.  Effect of nitric oxide synthase inhibitors in acute lung injury due to blunt lung trauma in rats.

Authors:  Aslı Gül Akgül; Deniz Şahin; Uğur Temel; Aykut Eliçora; Meltem Dillioğlugil; Hale Maral Kır; Özgür Doğa Özsoy; Kürşat Yıldız; Cüneyt Özer; Salih Topçu
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2019-01-01       Impact factor: 0.332

5.  Rhodiola crenulata and Its Bioactive Components, Salidroside and Tyrosol, Reverse the Hypoxia-Induced Reduction of Plasma-Membrane-Associated Na,K-ATPase Expression via Inhibition of ROS-AMPK-PKC ξ Pathway.

Authors:  Shih-Yu Lee; Li-Shian Shi; Hsin Chu; Min-Hui Li; Cheng-Wen Ho; Feng-Yi Lai; Chih-Yang Huang; Tsu-Chung Chang
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-06       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.